TLC-2716

N/A

Report date: 2024/08/22 20:00:11

Base Information

Drug NameTLC-2716
Drug Alias NameTLC-2716
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLiver X receptor inverse agonists
TargetsLiver X receptor
Therapy Area/IndicationsHypertriglyceridemiaMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandMexico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Liver Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrsoBio Inc
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemiaMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A